SIMEOLI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 867
EU - Europa 459
AS - Asia 449
AF - Africa 18
SA - Sud America 2
Totale 1.795
Nazione #
US - Stati Uniti d'America 840
SG - Singapore 186
IT - Italia 172
CN - Cina 124
HK - Hong Kong 121
NL - Olanda 72
DE - Germania 49
FI - Finlandia 45
IE - Irlanda 33
CA - Canada 26
FR - Francia 23
SE - Svezia 18
CI - Costa d'Avorio 17
GB - Regno Unito 11
IN - India 10
RU - Federazione Russa 9
CZ - Repubblica Ceca 7
UA - Ucraina 7
IR - Iran 5
RO - Romania 4
BR - Brasile 2
ES - Italia 2
ID - Indonesia 2
AT - Austria 1
BE - Belgio 1
DK - Danimarca 1
EG - Egitto 1
HR - Croazia 1
NO - Norvegia 1
PA - Panama 1
PL - Polonia 1
SI - Slovenia 1
VN - Vietnam 1
Totale 1.795
Città #
Chandler 177
Singapore 155
Hong Kong 121
Santa Clara 80
Amsterdam 69
Naples 55
Ashburn 49
Millbury 45
Boston 27
Des Moines 26
Princeton 23
Helsinki 21
Lawrence 20
Ottawa 20
Beijing 19
Nanjing 19
Napoli 17
Wilmington 15
Seattle 11
Rome 10
San Mateo 10
Munich 9
Dublin 7
Falkenstein 7
Nanchang 7
Brno 6
Frankfurt am Main 6
Jacksonville 6
Changsha 5
Hebei 5
Shanghai 5
Afragola 4
Ardabil 4
Augusta 4
Jiaxing 4
Kronberg 4
Milan 4
Portici 4
Toronto 4
Washington 4
Campobasso 3
Florence 3
Houston 3
Lappeenranta 3
Norwalk 3
Paris 3
Shenyang 3
Tianjin 3
Bangalore 2
Bari 2
Buffalo 2
Castrolibero 2
Cluj-Napoca 2
Dearborn 2
Fairfield 2
Lamezia Terme 2
Lanzhou 2
London 2
Moscow 2
Mumbai 2
Pittsburgh 2
Porto Alegre 2
Sant'Antimo 2
Schio 2
Turin 2
Villa Literno 2
West Jordan 2
Woodbridge 2
Altamura 1
Atripalda 1
Boardman 1
Brussels 1
Bucharest 1
Cairo 1
Castellammare di Stabia 1
Cernobbio 1
Chengdu 1
Cisano Bergamasco 1
Dallas 1
Dongguan 1
Edinburgh 1
Falls Church 1
Fuzhou 1
Handan 1
Herne Hill 1
Izhevsk 1
Jinan 1
Krefeld 1
Kunming 1
Leawood 1
Leipzig 1
Ljubljana 1
Los Angeles 1
Luoyang 1
Madrid 1
Marano Di Napoli 1
Middletown 1
Mugnano Di Napoli 1
Nantong 1
New York 1
Totale 1.184
Nome #
The 17β-hydroxysteroid dehydrogenase type 3 deficiency: a case report of an 18-year patient and review of the literature. 69
Neuropsychiatric disorders in Cushing's syndrome. 65
Effects of long-term combined treatment with somatostatin analogues and pegvisomant on cardiac structure and performance in acromegaly 55
Erratum to: The treatment with pasireotide in Cushing’s disease: effects of long–term treatment on tumor mass in the experience of a single center (Endocrine, (2015), 50, (725-740) DOI 10.1007/s12020-015-0557-2) 53
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE). 52
The treatment with pasireotide in Cushing's disease: effects of long-term treatment on tumor mass in the experience of a single center. 51
Adrenal Mass: Insight Into Pathogenesis and a Common Link With Insulin Resistance 51
Metabolic alterations and cardiovascular outcomes of cortisol excess 50
CORTISOL CIRCADIAN RHYTHM AND INSULIN RESISTANCE IN MUSCLE: EFFECT OF DOSING AND TIMING OF HYDROCORTISONE EXPOSURE ON INSULIN SENSITIVITY IN SYNCHRONIZED MUSCLE CELLS 50
The Glucocorticoid Analog Dexamethasone Alters the Expression and the Distribution of Dopamine Receptors and Enkephalin within Cortico-subcortical Regions. 49
Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit 49
The role of inferior petrosal sinus sampling in ACTH-dependent Cushing's syndrome:review and joint opinion statement by members of the Italian Society for Endocrinology, Italian Society for Neurosurgery, and Italian Society for Neuroradiology 48
The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma 48
Evaluation of the retinal nerve fibre layer and ganglion cell complex thickness in pituitary macroadenomas without chiasmal compression. 45
Pathophysiology of diabetes mellitus in Cushing's syndrome. 44
Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities 44
Cardiovascular disease in Cushing's syndrome: heart versus vasculature. 43
Cushing’s disease: the burden of illness 43
Severe impact of late diagnosis of congenital adrenal hyperplasia on gender identity, sexual orientation and function: case report and review of the literature 41
The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications 41
Characterization with hybrid imaging of cystic pheochromocytomas: Correlation with pathology 40
Vitamin D Reverts the Exosome-Mediated Transfer of Cancer Resistance to the mTOR Inhibitor Everolimus in Hepatocellular Carcinoma 40
Imbalanced cortisol concentrations in glycogen storage disease type I: Evidence for a possible link between endocrine regulation and metabolic derangement 39
Is mortality in Cushing's disease reversible with remission? 38
Effect of Cabergoline on Metabolism in Prolactinomas. 37
Long-term high-dose l-arginine supplementation in patients with vasculogenic erectile dysfunction: a multicentre, double-blind, randomized, placebo-controlled clinical trial 37
Bone metabolism in patients with type 1 neurofibromatosis: key role of sun exposure and physical activity 37
Influence of bisphenol a on type 2 diabetes mellitus 36
Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials 35
The dopaminergic control of Cushing's syndrome 33
The degree of urinary hypercortisolism is not correlated with the severity of cushing’s syndrome 32
The treatment with pasireotide in Cushing’s disease: effect of long-term treatment on clinical picture and metabolic profile and management of adverse events in the experience of a single center 32
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 32
Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial. 31
Current management and outcome of pregnancies in women with adrenal insufficiency: experience from a multi-center survey 31
Is diabetes in Cushing's syndrome only a consequence of hypercortisolism? 27
Pituitary magnetic resonance imaging in Cushing’s disease 26
Circulating myomiRNAs as biomarkers in patients with Cushing's syndrome 24
Safety of long-term treatment with cabergoline on cardiac valve disease in patients with prolactinomas 24
Etiology-, Sex-, and Tumor Size-Based Differences in Adrenocorticotropin-Dependent Cushing Syndrome 23
Cushing's disease: adrenal steroidogenesis inhibitors 20
The role of mTOR pathway as target for treatment in adrenocortical cancer 20
Cardiac magnetic resonance reveals biventricular impairment in Cushing's syndrome: a multicentre case-control study 19
Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion 19
COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency 19
Characterization of Atypical Pheochromocytomas with Correlative MRI and Planar/Hybrid Radionuclide Imaging: A Preliminary Study 18
Endocrine system involvement in patients with RASopathies: A case series 17
MR imaging characterization of pheochromocytoma: a comparison between typical and atypical tumor lesions 17
Glucocorticoid Receptor Antagonism Upregulates Somatostatin Receptor Subtype 2 Expression in ACTH-Producing Neuroendocrine Tumors: New Insight Based on the Selective Glucocorticoid Receptor Modulator Relacorilant 17
Exploring sexual function in adrenal insufficiency: findings from the Dual RElease hydrocortisone versus conventionAl glucocorticoid replaceMent therapy in hypocortisolism (DREAM) trial 14
Susceptibility and characteristics of infections in patients with glucocorticoid excess or insufficiency: the ICARO tool 14
The environment and male reproductive system: the potential role and underlying mechanisms of cadmium in testis cancer 14
Osilodrostat: A Novel Potent Inhibitor of 11-Beta-Hydroxylase for the Treatment of Cushing's Syndrome 14
Remission in Cushing’s disease is predicted by cortisol burden and its withdrawal following pituitary surgery 13
Endocrine involvement in hepatic glycogen storage diseases: pathophysiology and implications for care 12
Circadian clock disruption impairs immune oscillation in chronic endogenous hypercortisolism: a multi-level analysis from a multicentre clinical trial 9
Diurnal cortisol profiles across pregnancy: challenges in the current state of knowledge 9
Differential diagnosis between Cushing's syndrome and non-neoplastic hypercortisolism: are we getting there? 8
Who and how to screen for endogenous hypercortisolism in patients with mood disorders 7
Relacorilant or surgery improved hemostatic markers in Cushing syndrome 6
Vein wall thickness and severity of pulmonary involvement due to sars n-cov2 virus infection 5
Genetic Heterogeneity in Adrenal Insufficiency 3
Totale 1.939
Categoria #
all - tutte 10.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.063


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202063 0 0 0 0 0 0 1 2 12 9 20 19
2020/202164 1 1 1 3 9 5 5 1 5 1 32 0
2021/2022291 1 3 5 1 3 18 3 10 39 39 66 103
2022/2023441 43 28 15 26 64 46 12 43 76 73 13 2
2023/2024301 13 47 29 36 13 27 8 37 5 19 37 30
2024/2025566 97 103 21 22 40 138 145 0 0 0 0 0
Totale 1.939